Noveris Health Sciences Inc. (CSE:NVRS)

Market Cap	128.81M +20,757.4%
Revenue (ttm)	n/a
Net Income	2.29M
EPS	1.85
Shares Out	58.55M
PE Ratio	1.19
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	96,776
Average Volume	34,296
Open	2.100
Previous Close	1.980
Day's Range	1.920 - 2.350
52-Week Range	0.120 - 2.350
Beta	1.94
RSI	92.25
Earnings Date	Mar 31, 2026

About Noveris Health Sciences

Noveris Health Sciences Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. It also develops MYCO-005, MYCO-006, and MYCO-007 for MDMA and psilocybin analogs. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. Noveris Health Sciences...

• Industry: Agricultural Production Crops
• Founded: 2013
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: NVRS